Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 2/20 | 0.46 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.46 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.46 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.46 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.46 |
| ▸ | GSR | P00390 | 2/20 | 0.46 |
| ▸ | GRM8 | O00222 | 1/20 | 0.46 |
| ▸ | GRM6 | O15303 | 1/20 | 0.46 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.46 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | GRM5 | P41594 | 1/20 | 0.46 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.46 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.46 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.46 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.46 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.46 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.46 |
| ▸ | GRIK3 | Q13003 | 1/20 | 0.46 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23716476 | 1.00 | GRIK1 (0.46) | GRIK1SLC1A3SLC1A2SLC1A1GRIK2 | |
| SCHEMBL28335433 | 0.89 | SLC1A1 (0.42) | GRIK1SLC1A3SLC1A2SLC1A1GRIK2 | |
| SCHEMBL17077617 | 0.89 | SLC1A1 (0.42) | GRIK1SLC1A3SLC1A2SLC1A1GRIK2 | |
| SCHEMBL9086724 | 0.83 | GRIK1 (0.50) | GRIK1SLC1A3SLC1A2SLC1A1GRIK2 | |
| SCHEMBL9085219 | 0.83 | GRM8 (0.60) | GRIK1SLC1A3SLC1A2SLC1A1GRIK2 | |
| SCHEMBL9085224 | 0.83 | GRM8 (0.60) | GRIK1SLC1A3SLC1A2SLC1A1GRIK2 | |
| SCHEMBL9086732 | 0.83 | GRIK1 (0.50) | GRIK1SLC1A3SLC1A2SLC1A1GRIK2 | |
| SCHEMBL18030268 | 0.83 | GRM8 (0.60) | GRIK1SLC1A3SLC1A2SLC1A1GRIK2 | |
| SCHEMBL23716475 | 0.83 | SLC1A3 (0.46) | GRIK1SLC1A3SLC1A2SLC1A1GRIK2 | |
| SCHEMBL6063405 | 0.83 | SLC1A3 (0.46) | GRIK1SLC1A3SLC1A2SLC1A1GRIK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3144001-B1 | COMPOSITIONS OF SELENOORGANIC COMPOUNDS AND METHODS OF USE THEREOF | ALLTECH INC (US) | 2021-08-11 | — | — | EP | claimed |
| US-9642874-B2 | Compositions of selenoorganic compounds and methods of use thereof | ALLTECH, INC. (US) | 2017-05-09 | — | — | US | claimed |
| WO-2017048253-A1 | COMPOSITIONS OF SELENOORGANIC COMPOUNDS AND METHODS OF USE THEREOF | ALLTECH, INC. (US) | 2017-03-23 | — | — | WO | claimed |
| EP-3144001-A1 | COMPOSITIONS OF SELENOORGANIC COMPOUNDS AND METHODS OF USE THEREOF | Alltech, Inc. (US) | 2017-03-22 | — | — | EP | claimed |
| US-20160082033-A1 | COMPOSITIONS OF SELENOORGANIC COMPOUNDS AND METHODS OF USE THEREOF | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT | 2016-03-24 | — | — | US | claimed |
| US-20160045533-A1 | COMPOSITIONS OF SELENOORGANIC COMPOUNDS AND METHODS OF USE THEREOF | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT | 2016-02-18 | — | — | US | claimed |
| EP-3144001-B1 | COMPOSITIONS OF SELENOORGANIC COMPOUNDS AND METHODS OF USE THEREOF | ALLTECH INC (US) | 2021-08-11 | — | — | EP | disclosed |
| EP-3116511-B1 | COMPOSITIONS OF SELENOORGANIC COMPOUNDS AND METHODS OF USE THEREOF | ALLTECH INC (US) | 2020-08-26 | — | — | EP | disclosed |
| US-10201559-B2 | Compositions of selenoorganic compounds and methods of use thereof | ALLTECH, INC. (US) | 2019-02-12 | — | — | US | disclosed |
| US-10201558-B2 | Compositions of selenoorganic compounds and methods of use thereof | ALLTECH, INC. (US) | 2019-02-12 | — | — | US | disclosed |
| US-9642874-B2 | Compositions of selenoorganic compounds and methods of use thereof | ALLTECH, INC. (US) | 2017-05-09 | — | — | US | disclosed |
| WO-2017048253-A1 | COMPOSITIONS OF SELENOORGANIC COMPOUNDS AND METHODS OF USE THEREOF | ALLTECH, INC. (US) | 2017-03-23 | — | — | WO | disclosed |
| WO-2017048252-A1 | COMPOSITIONS OF SELENOORGANIC COMPOUNDS AND METHODS OF USE THEREOF | ALLTECH, INC. (US) | 2017-03-23 | — | — | WO | disclosed |
| EP-3144001-A1 | COMPOSITIONS OF SELENOORGANIC COMPOUNDS AND METHODS OF USE THEREOF | Alltech, Inc. (US) | 2017-03-22 | — | — | EP | disclosed |
| EP-3116511-A1 | COMPOSITIONS OF SELENOORGANIC COMPOUNDS AND METHODS OF USE THEREOF | Alltech, Inc. (US) | 2017-01-18 | — | — | EP | disclosed |
| US-20160361338-A1 | COMPOSITIONS OF SELENOORGANIC COMPOUNDS AND METHODS OF USE THEREOF | ALLTECH, INC. (US) | 2016-12-15 | — | — | US | disclosed |
| US-20160082033-A1 | COMPOSITIONS OF SELENOORGANIC COMPOUNDS AND METHODS OF USE THEREOF | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT | 2016-03-24 | — | — | US | disclosed |
| US-20160045533-A1 | COMPOSITIONS OF SELENOORGANIC COMPOUNDS AND METHODS OF USE THEREOF | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT | 2016-02-18 | — | — | US | disclosed |
| WO-2015137983-A1 | COMPOSITIONS OF SELENOORGANIC COMPOUNDS AND METHODS OF USE THEREOF | ALLTECH, INC. (US) | 2015-09-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160045533-A1 | COMPOSITIONS OF SELENOORGANIC COMPOUNDS AND METHODS OF USE THEREOF | SCLY, BHMT2, CBS | GRIK1 1127/4885SLC1A3 350/4885SLC1A2 206/4885 |
| US-10201559-B2 | Compositions of selenoorganic compounds and methods of use thereof | SHMT2, FPGS, MTR | GRIK1 1133/4885SLC1A3 845/4885SLC1A2 606/4885 |
| US-20160361338-A1 | COMPOSITIONS OF SELENOORGANIC COMPOUNDS AND METHODS OF USE THEREOF | SHMT2, FPGS, MTR | GRIK1 1133/4885SLC1A3 845/4885SLC1A2 606/4885 |
| US-20160082033-A1 | COMPOSITIONS OF SELENOORGANIC COMPOUNDS AND METHODS OF USE THEREOF | PSEN2, PSEN1, BACE1 | GRIK1 1668/4885SLC1A3 1613/4885SLC1A2 1229/4885 |
| US-10201558-B2 | Compositions of selenoorganic compounds and methods of use thereof | PSEN2, PSEN1, BACE1 | GRIK1 1668/4885SLC1A3 1613/4885SLC1A2 1229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.